healthcare.digital February 23, 2025
Lloyd Price

Exec Summary:

The HealthTech mergers and acquisitions landscape in 2025, particularly for distressed companies, is shaping up to be a complex and dynamic space, driven by a mix of financial pressures, strategic repositioning, and evolving market demands.

Distress in HealthTech has been brewing for a while, amplified by the post-pandemic reality check. Many startups that ballooned during the 2020-2022 digital health boom fuelled by cheap capital and telehealth hype, are now struggling.

High interest rates, tighter venture funding, and a shift toward profitability over growth have left weaker players exposed. Kaufman Hall’s 2024 data already showed a record 30.6% of hospital M&A deals involving distressed parties, up from 27.7% in 2023, and this trend is spilling into HealthTech.

Companies...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: Digital Health, Health IT, Mergers & Acquisitions / JV, Technology, Trends
Selling a practice: How to remain HIPAA compliant during a sale
Where do the opportunities exist in today's distressed HealthTech M&A landscape in the UK?
The 'buzz of excitement' behind Duke Health's CHS hospital acquisition
5 huge hospital, health system deals in 30 days
Cash-Strapped Gene Therapy Firm Bluebird Bio Agrees to Acquisition by Private Equity

Share This Article